The DEA will hold hearings on whether to lessen restrictions on marijuana where it would be in the same class of drugs as ...
DEA to hold hearing on rescheduling marijuana to Schedule III on December 2, focusing on logistics, not testimonies.
Pennington pointed out in his motion that the DEA approved as witnesses officials from Nebraska, which opposes ...
Now a lawsuit says DEA acting in bad faith over marijuana. David Heldreth, CEO of psychedelic research firm Panacea Plant ...
A DEA administrative law judge has denied MedPharm's motion to participate in the December 2 marijuana rescheduling ...
The motion, which asks the DOJ to take over moving cannabis down the list, argues the DEA has "stacked the deck" against ...
The cannabis industry is concerned about the direction of regulations – and the DEA is still against the plant.